New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
12:04 EDTSHPGShire reaches agreement with U.S. government, to record $57.5M charge in Q4
Shire announced that it has reached an agreement in principle to resolve the previously disclosed civil investigation into Shire's U.S. sales and marketing practices relating to Adderall XR, Vyanse and Daytrana. The investigation was led by the U.S. Attorney's Office for the Eastern District of Pennsylvania, and Shire disclosed the investigation in 2009. The agreement also addresses sales and marketing practices relating to Lialda and Pentasa pursuant to a subsequent voluntary disclosure made by Shire. Shire has recorded a $57.5M charge in Q4, comprised of the agreement in principle amount, interest and costs.
News For SHPG From The Last 14 Days
Check below for free stories on SHPG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2013
10:03 EDTSHPGShire advances after report renews takeover speculation
Subscribe for More Information
07:27 EDTSHPGAmerican Psychiatric Association to host annual meeting
Subscribe for More Information
07:01 EDTSHPGSangamo BioSciences announces positive data for Vivo Protein platform
Sangamo BioSciences (SGMO) announced the presentation of new data demonstrating the successful application of Sangamo's proprietary In Vivo Protein Replacement Platform to produce therapeutically relevant levels of Factor VIII in a mouse model. Sangamo has partnered with Shire (SHPG) to develop ZFP Therapeutics for both hemophilia A and B using this approach.
06:30 EDTSHPGLeerink estimates Shire takeout value at least $110 per share
Leerink says a takeover price for Shire (SHPG) would need to be at least $110 per share in order to get the company's board to consider a sale. The firm notes a Daily Mail report last night said Bristol-Myers (BMY) has engaged advisors to study an acquisition of Shire and that Shire's CEO has contacted bankers to consider anti-takeover measures. Leerink believes a Bristol-Myers takeover of Shire would make sense and keeps an Outperform rating on Shire.
06:25 EDTSHPGShire may return cash to thwart takeover, Daily Mail reports
Subscribe for More Information
May 14, 2013
07:24 EDTSHPGEBD Group to host a conference
BioTrinity 2013 is being held in Newbury, England on May 14-16.

Sign up for a free trial to see the rest of the stories you've been missing.